Meet the Proteona team at the Single Cells: Technology to Biology Symposium in Singapore
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
Proteona announced that Dr Jonathan Scolnick will present at the Single Cells: Technology to Biology Symposium in Singapore on Tuesday, the 26th February, 2019. The event is part of Cell Symposia.
Dr Scolnick's talk is titled "ESCAPE RNA sequencing: Simultaneous single-cell protein, gene expression and mutation analysis to profile the tumors". It will take place at 14:30pm at the conference venue.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.